Certificate in Psychedelic Assisted Therapy: Difference between revisions

From BurnZero
No edit summary
No edit summary
Line 1: Line 1:
The provision of a supportive therapeutic setting prior to, during, and following drug administration is now the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. To fill this requirement, a variety of psychedelic-assisted psychotherapy (PAP) models have been developed. A recent analysis performed in June 2022<ref>'''The Psychotherapeutic Framing of Psychedelic Drug Administration'''. Front. Psychol.,  Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>, has found many lacking in rigour.
The provision of a supportive therapeutic setting prior to, during, and following drug administration is now the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. To fill this requirement, a variety of psychedelic-assisted psychotherapy (PAP) models and certifications (CPAT) have been developed. By comparing and contrasting each offering a new [[Open Source Psychedelic-Assisted Therapy]] has been developed.


 
=== CPAT Content ===
Created from intensive analysis of current Best Practice standards, including protocols created by MAPS and the REBUS model created at Imperial College London, this training certificate adheres to global best practices.
All PAP models contain three phases<ref>'''The Psychotherapeutic Framing of Psychedelic Drug Administration'''. Front. Psychol., Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. Preparation sessions make up the first stage and are intended to get individuals ready to benefit from the medication. The second stage of therapy is referred to as the medicine session(s), which refers to the day(s) when medication is administered. The third phase, often known as "integration" (Gorman et al., 2021) involves a process of reflection on the medicine session(s) and how it could motivate cognitive and behavioural changes that last after the course of therapy.


'''References'''
'''References'''
<references />
<references />

Revision as of 08:13, 9 August 2022

The provision of a supportive therapeutic setting prior to, during, and following drug administration is now the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. To fill this requirement, a variety of psychedelic-assisted psychotherapy (PAP) models and certifications (CPAT) have been developed. By comparing and contrasting each offering a new Open Source Psychedelic-Assisted Therapy has been developed.

CPAT Content

All PAP models contain three phases[1]. Preparation sessions make up the first stage and are intended to get individuals ready to benefit from the medication. The second stage of therapy is referred to as the medicine session(s), which refers to the day(s) when medication is administered. The third phase, often known as "integration" (Gorman et al., 2021) involves a process of reflection on the medicine session(s) and how it could motivate cognitive and behavioural changes that last after the course of therapy.

References

  1. The Psychotherapeutic Framing of Psychedelic Drug Administration. Front. Psychol., Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: https://doi.org/10.3389/fpsyg.2022.866018

Share your opinion